- News & Features
New research, published by the Centers for Disease Control and Prevention, indicates that arthritis patients aren’t receiving sufficient counseling about weight loss.
CreakyJoints to Facilitate Grant Program UPPER NYACK, NY (May X, 2018) – CreakyJoints today announced that the PCORnet Autoimmune and...
Spondyloarthritis (SpA) patients who took the nonsteroidal anti-Inflammatory drug (NSAID) diclofenac were at elevated risk for heart attack.
The FDA findings are based upon a Dec. 2016 study of more than 24,000 osteoarthritis and rheumatoid arthritis patients.
Poring over data from more than 123,000 people in two different studies, Harvard researchers identified five lifestyle practices that can extend life.
The U.S. could face a shortage of more than 4,100 full-time rheumatologists by 2030, according to new research published in Arthritis Care & Research.
"The placebo effect is still an effect and a very important one."
Researchers found that younger patients, as well as those whose disease was more active, were likelier to stop taking methotrexate due to ineffectiveness.
Researchers, writing in the Journal of the American Geriatrics Society, have found that knee osteoarthritis patients are likelier to develop depression.
Our first "Get a Handle on Arthritis" contest had an amazing response with over 300 people entering for a chance to win a LoveHandle phone grip.